VeriMomsodium c12-15 pareth-7 sulfonate est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive warning found for sodium C12–15 pareth-7 sulfonate. Regulatory and safety-assessment sources treat ethoxylated alkyl sulfonate surfactants as low systemic-reprotoxicity in cosmetic use (CIR / SCCS style conclusions) and there are no peer-reviewed reports of teratogenicity or human reproductive effects for this specific ingredient. Dermal cosmetic use can give low but measurable exposure; therefore exposure score is 1. Sources: ECHA Annex VI (no harmonised classification), CIR/SCCS style safety literature, PubChem/CosIng entries (no reproductive flags).
Related ingredients
Frequently asked questions
- sodium c12-15 pareth-7 sulfonate est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive warning found for sodium C12–15 pareth-7 sulfonate. Regulatory and safety-assessment sources treat ethoxylated alkyl sulfonate surfactants as low systemic-reprotoxicity in cosmetic use (CIR / SCCS style conclusions) and there are no peer-reviewed reports of teratogenicity or human reproductive effects for this specific ingredient. Dermal cosmetic use can give low but measurable exposure; therefore exposure score is 1. Sources: ECHA Annex VI (no harmonised classification), CIR/SCCS style safety literature, PubChem/CosIng entries (no reproductive flags).
- sodium c12-15 pareth-7 sulfonate est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-related toxicity or known mechanisms for transfer into breast milk for this ingredient; no harmonised hazard classification. Dermal cosmetic use implies low but measurable maternal systemic exposure, so a low exposure score is used. Sources: ECHA records (no harmonised classification), CosIng/PubChem (no lactation concerns), absence of CIR/SCCS warnings.
- sodium c12-15 pareth-7 sulfonate est-il sûr pour la peau de bébé ?
- No infant-specific reproductive or developmental hazards identified for this surfactant. However, immature infant skin has higher permeability and higher surface-area-to-weight, so exposure score is increased by +1 from adult (adult e=1 → infant e=2). No infant-specific adverse data found in regulatory or peer-reviewed sources. Sources: CosIng/PubChem (ingredient identity and typical use), ECHA (no harmonised classification), toxicology literature absence per CIR/SCCS practice.
- Comment VeriMom évalue-t-il sodium c12-15 pareth-7 sulfonate ?
- VeriMom évalue sodium c12-15 pareth-7 sulfonate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à sodium c12-15 pareth-7 sulfonate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à sodium c12-15 pareth-7 sulfonate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.